Valeant to Acquire Medicis for $2.6 Billion

04.09.2012 - Valeant Pharmaceuticals International agreed on Monday to buy Medicis Pharmaceutical for $2.6 billion in cash, in a deal that will add Botox competitor Dysport and other skin care...